Sanofi Deferred Tax Expense Income
Sanofi (SNYNF) reported Deferred Tax Expense Income of -EUR 2.39 billion for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-17.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:DeferredTaxExpenseIncome · last filed 2026-02-17
| Period end | Deferred Tax Expense Income 6 month | Deferred Tax Expense Income 6 month as first filed | Deferred Tax Expense Income 12 month | Deferred Tax Expense Income 12 month as first filed |
|---|---|---|---|---|
| 2025-12-31 | -2.39B EUR 20-F · filed 2026-02-17 | |||
| 2025-06-30 | -491.00M EUR 6-K · filed 2025-10-27 | |||
| 2024-12-31 | -948.00M EUR 20-F · filed 2026-02-17 | |||
| 2024-06-30 | -729.00M EUR 6-K · filed 2025-10-27 | -780.00M EUR 6-K · filed 2024-07-25 | ||
| 2023-12-31 | -1.23B EUR 20-F · filed 2026-02-17 | -958.00M EUR 20-F · filed 2024-02-23 | ||
| 2023-06-30 | -441.00M EUR 6-K · filed 2024-07-25 | |||
| 2022-12-31 | -722.00M EUR 20-F · filed 2025-02-13 | -768.00M EUR 20-F · filed 2023-02-24 | ||
| 2022-06-30 | -592.00M EUR 6-K · filed 2023-07-28 | |||
| 2021-12-31 | -350.00M EUR 20-F · filed 2024-02-23 | |||
| 2021-06-30 | -128.00M EUR 6-K · filed 2022-07-28 | -124.00M EUR 6-K · filed 2021-07-29 | ||
| 2020-12-31 | -106.00M EUR 20-F · filed 2023-02-24 | -99.00M EUR 20-F · filed 2021-03-04 | ||
| 2020-06-30 | -133.00M EUR 6-K · filed 2021-07-29 | |||
| 2019-12-31 | -1.77B EUR 20-F · filed 2022-02-23 | -1.75B EUR 20-F · filed 2020-03-05 | ||
| 2019-06-30 | -815.00M EUR 6-K · filed 2020-07-29 | |||
| 2018-12-31 | -731.00M EUR 20-F · filed 2021-03-04 | |||
| 2017-12-31 | -909.00M EUR 20-F · filed 2020-03-05 | |||
| 2016-12-31 | -544.00M EUR 20-F · filed 2019-03-08 | -543.00M EUR 20-F/A · filed 2018-03-16 | ||
| 2015-12-31 | -1.27B EUR 20-F/A · filed 2018-03-16 |